N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling

BACKGROUND: Glioblastomas multiforme (GBM) is the most devastating primary intracranial malignancy lacking effective clinical treatments. Notch2 has been established to be a prognostic marker and probably involved in GBM malignant progression. N-acetylcysteine (NAC), a precursor of intracellular glu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: Deng, Jie, Liu, An-Dong, Hou, Guo-Qing, Zhang, Xi, Ren, Kun, Chen, Xuan-Zuo, Li, Shawn S. C., Wu, Yao-Song, Cao, Xuan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319015/
https://ncbi.nlm.nih.gov/pubmed/30606241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-1016-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars